ADAM II Abstract

Cambridge, MA

Lexington, MA

Hadley, MA

Bethesda, MD

Chicago, IL

Abt Associates Inc.

55 Wheeler Street

Cambridge, MA 02138

Arrestee Drug Abuse Monitoring (ADAM II)

Abstract

Request for

OMB Review

January 12, 2007

Prepared by

Lisa Magged

Sarah Kuck

Dana Hunt

Prepared for

Robert L. Cohen

Executive Office of the President

Office of National Drug Control Policy (Planning and Budget)

Washington, DC 20503

Contents

Arrestee Drug Abuse Monitoring Program (ADAM) II 2

Abstract 2

Part A: Justification 2

1. Circumstances That Make Collection of Data Necessary 2

2. Purposes and Uses of the Data 5

3. Use of Improved Information Technology to Reduce Burden 6

4. Efforts to Identify and Avoid Duplication 7

5. Efforts to Minimize Burden on Small Businesses or Other Entities 7

6. Consequences If the Information Is Not Collected or Is Collected Less Frequently 7

7. Special Circumstances Requiring Collection of Information in a Manner Inconsistent with Section 1320.5(d)(2) of the Code of Federal Regulations 8

8. Public Comment Received on Federal Register Notice 8

9. Incentives to Respondents 8

10. Assurances of Confidentiality Provided to Respondents 8

11. Justification for Questions of a Sensitive Nature 9

12. Estimate of Information Collection Burden 9

13. Estimate of Total Annual Cost Burden 10

14. Estimates of Annualized Costs 10

15. Change in Annual Reporting Burden 10

16. Plans for Tabulation and Publication of Results 10

17. OMB Expiration Date 11

18. Exceptions to Certification Statement 11

Part B: Collection of Information Employing Statistical Methods 12

1. Respondent Universe and Sampling Methods 12

2. Information Collection Procedures 15

3. Methods to Maximize Response Rates 22

4. Tests of Procedures 22

5. Individuals Consulted on Statistical Aspects of the Design 25

Arrestee Drug Abuse Monitoring Program (ADAM) II

Abstract

The Office of National Drug Control Policy’s (ONDCP’s) mission, since its authorization in 1988, has been to establish the Nation’s drug control policy, to set priorities for advancing that policy, and to identify and monitor objective measures of that policy’s success. The original Arrestee Drug Abuse Monitoring program (ADAM) was a critical source of data for ONDCP in meeting its objectives, and its demise in 2003 left a serious gap in accurate and timely information on trends in drug use.

The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The original OMB approval for this collection authorized 100,000 responses and a time burden of 62,500 hours (OMB control # 1121-0137). That authorization expired in 2005.

With ADAM II, ONDCP and its contractor, Abt Associates, Inc., will initiate a new data collection that will replicate the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II will implement two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously approved ADAM survey, the ADAM II survey will collect data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male¹ arrestees within 48 hours of arrest. Data collection will take place across two back-to-back quarters in each of 10 counties from a county-based representative sample of 250 male arrestees per quarter for a total of 500 arrestees annually per site or a total of 5000 arrestees across sites annually. Collection will occur in two cycles at each site to provide estimates for two calendar quarters each year. One year of collection will occur beginning April 1, 2007 and ending March 31, 2008. If additional data collection periods are optioned by ONDCP, subsequent cycles of back-to-back data collection will occur beginning April 1, 2008. Participation is voluntary and confidential, and the procedures will include a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Though a convenience sample of female and juvenile arrestees was a part of the previous ADAM program, those groups will be excluded from this effort for the purposes of economy.

1 ADAM II will obtain data from male arrestees because the adult male component was the most robust segment of the ADAM study.

Abt Associates Inc. Request for OMB Review 0